Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Vaxart, Inc.
| Metric | Vaxart, Inc. VXRTHealthcare |
|---|---|
| Quality Score | 75 / 100 |
| Revenue (latest) | $237M |
| Net income (latest) | $16M |
| Operating margin | 7.6% |
| Net margin | 6.9% |
| Return on equity | 18.6% |
| Return on assets | 8.8% |
| Return on capital (ROCE) | 18.2% |
| Debt / equity | 1.12× |
| Revenue growth (YoY) | 726.7% |
| Altman Z″ (distress) | -4.73 |
| Accruals / assets | 4.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.